(Q73586771)
Statements
A phase I/II study of idarubicin (Ida) with continuous infusion fludarabine (F-ara-A) and cytarabine (ara-C) for refractory or recurrent pediatric acute myeloid leukemia (AML) (English)
A Leahey
K Kelly
L B Rorke
scientific article published on 01 July 1997